Related references
Note: Only part of the references are listed.Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials
M. Tarazi et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
Ronald F. van Vollenhoven et al.
LANCET (2018)
Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study
Dominik Samotij et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Alopecias in lupus erythematosus
Josef Symon Salgado Concha et al.
LUPUS SCIENCE & MEDICINE (2018)
Lupus community panel proposals for optimising clinical trials: 2018
Joan T. Merrill et al.
LUPUS SCIENCE & MEDICINE (2018)
A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus
M. E. Ogunsanya et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The impact of skin damage due to cutaneous lupus on quality of life
S. M. Verma et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance
Laura Holloway et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Cutaneous lupus erythematosus: Diagnosis and treatment
L. G. Okon et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2013)
Quality of Life Differences Between Responders and Nonresponders in the Treatment of Cutaneous Lupus Erythematosus
Aileen Y. Chang et al.
JAMA DERMATOLOGY (2013)
Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
Rachel Klein et al.
ARCHIVES OF DERMATOLOGY (2011)
Quality of life in cutaneous lupus erythematosus
Rachel Klein et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life
JL Hundley et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
J Albrecht et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Cutaneous lupus erythematosus: a review
P Patel et al.
DERMATOLOGIC CLINICS (2002)
Share Paper
